Metabolic syndrome and cancer risk: A bidirectional two-sample Mendelian randomization study
Authors:
Open Access
- 4 June 2025
- journal article
- Published by Elsevier in Experimental Gerontology
- Vol. 207, 112802
Abstract
No abstract availableKeywords
Funding Information
- Xi'an Jiaotong University
- National Natural Science Foundation of China (82174164)
This publication has 65 references indexed in Scilit:
- Association between metabolic syndrome and gastric cancer risk: results from the Health Examinees StudyGastric Cancer, 2023
- Metabolic Syndrome and Prostate Cancer Risk: A Population Case-control StudyArchives of Medical Research, 2022
- Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian RandomizationJAMA, 2021
- Metabolic syndrome and the risk of colorectal cancer: a systematic review and meta-analysisInternational Journal of Colorectal Disease, 2021
- The Global Epidemic of the Metabolic SyndromeCurrent Hypertension Reports, 2018
- Prevention and treatment of cancer targeting chronic inflammation: research progress, potential agents, clinical studies and mechanismsScience China Life Sciences, 2017
- Metabolic factors and blood cancers among 578,000 adults in the metabolic syndrome and cancer project (Me-Can)Annals of Hematology, 2012
- Understanding obesity and endometrial cancer risk: opportunities for preventionAmerican Journal of Obstetrics and Gynecology, 2011
- Metabolic syndrome increases the risk of primary liver cancer in the United States: A study in the SEER-medicare databaseHepatology, 2011
- Epidemiological aspects of neoplasms in diabetesActa Diabetologica, 2010